Split type atomizing eye cover and self-adaptive atomizing nursing system thereof

Abstract

This application relates to the technical field of eye care products and nebulizer devices, and particularly to a split-type nebulizer eye mask, comprising: an eye mask body and a nebulizer. The nebulizer includes: a nebulizer shell, a liquid storage chamber, a liquid storage chamber cover, a detachable liquid receiving cup, a covered heating and cooling tube, an ultrasonic nebulizing plate, a mist flow guide plate, and a mist outlet cover plate. The covered heating and cooling tube and the ultrasonic nebulizing plate are installed in the nebulization chamber. The liquid storage chamber is assembled in the liquid storage chamber assembly cavity. The lower section of the mist flow guide plate is assembled to the mist outlet of the covered heating and cooling tube. The rear part of the nebulizer shell is assembled to the mounting cavity of the eye mask body. The mist outlet extends out of the nebulization hole of the mounting cavity. The top of the mist flow guide plate extends out of the operation hole of the mounting cavity. The mist outlet cover plate is fitted to the mist outlet, and the mist outlet through holes on its left and right sides are separated on both sides of the mist flow guide plate. The detachable liquid receiving cup is installed in the liquid receiving cup assembly cavity, and the liquid collection channel of the covered heating and cooling tube is connected to the detachable liquid receiving cup.

Description

Technical Field

[0001] This application relates to the technical field of eye care products and atomizing care devices, and in particular to a split-type atomizing eye mask and its adaptive atomizing care system. Background Technology

[0002] With the widespread use of electronic devices and the increase in prolonged close-range eye use, eye fatigue, dryness, mild inflammation, and tear film instability are becoming increasingly common. Ultrasonic atomizing eye masks, by atomizing medication into micron-sized particles and applying them to the periorbital area, can provide some moisturizing and soothing effects, becoming an important tool for relieving eye discomfort. However, existing ultrasonic atomizing eye masks still have the following structural defects: 1. The atomizing chamber and the main body of the ultrasonic atomizing goggle are an integral structure, which cannot be disassembled or separated. After long-term use, the ultrasonic atomizing plate is prone to drying out and clogging the pores. It can usually be restored by wiping with saline solution. However, since the ultrasonic atomizing goggle is an integral structure, it is difficult to perform targeted maintenance and cleaning on the ultrasonic atomizing plate and its surrounding area, which affects the long-term atomization effect. In addition, the integral ultrasonic atomizing goggle has a low degree of modularity. Once the atomizing module, liquid carrying module or local structure is damaged, the whole thing often needs to be replaced, which is not conducive to functional upgrades and maintenance replacement.

[0003] 2. During the atomization process, some of the mist forms condensation inside the eye mask cavity. This condensation will either remain directly or evaporate naturally and cannot be recycled. This not only affects the internal environment and user experience of the ultrasonic atomizing eye mask, but also wastes the medication and reduces the atomization effect.

[0004] 3. Most existing ultrasonic atomizing eye masks adopt a single-outlet mist output or a single fixed flow output design, which usually assumes that the left and right eye areas receive similar or even the same amount of mist. However, the conditions of the left and right eyes of different users are not completely the same, and the fixed distribution method is difficult to meet the differentiated care needs. In addition, due to the influence of usage time, pore blockage and internal flow field, the amount of mist output from different positions of the ultrasonic atomizing plate is not always absolutely uniform. If there is a lack of effective flow guiding structure, the mist may deviate after entering the eye mask, affecting the consistency of care for the left and right eye areas.

[0005] 4. The lack of an effective diversion and flow control structure in the airway design leads to unstable mist distribution in the left and right eye areas, further affecting the consistency of nursing care.

[0006] 5. Existing ultrasonic atomizing goggles mostly use heating methods such as heating the base plate to heat the liquid or heating the entire periphery of the atomizing chamber. However, when the mist passes through the heating area in the airflow path, the heat exchange efficiency is low, resulting in uneven heating. In addition, the coupling between the existing heating method and the mist flow path is not high. Heat needs to be conducted through a long heating path to affect the mist, resulting in significant heat loss. It is impossible to achieve rapid and uniform heating without affecting the atomization effect. Furthermore, existing ultrasonic atomizing goggles lack the ability to achieve cold mist care, making it difficult to adapt to different care scenarios.

[0007] 6. Most existing ultrasonic nebulizer goggles use a fixed power operating mode, which cannot be dynamically adjusted according to the remaining amount of medication, the characteristics of the medication, and the user's preset care duration. For example, when there is a lot of medication, a fixed low power will reduce efficiency, while when there is a little medication, a fixed high power may cause the care process to end prematurely. In addition, existing ultrasonic nebulizer goggles usually lack the function of recognizing the state of the medication and matching adaptive nebulization strategies, and the level of intelligence is insufficient, which cannot meet the personalized and precise care needs of users. Summary of the Invention

[0008] This application provides a split-type atomizing eye mask and its adaptive atomizing care system. Through a combination of modular structural design, independent collection of condensate, split-flow left and right mist volume adjustment, end-point hot and cold adjustment, and sensor feedback control, it solves the problems existing in current atomizing eye masks.

[0009] To solve the above-mentioned technical problems, this application provides the following technical solution: A split-type atomizing goggles includes: a goggles body and an atomizer. The goggles body has an inwardly recessed mounting cavity, with an atomizing hole penetrating the inside and outside in the middle of the mounting cavity, and an operating hole penetrating the inside and outside in the top of the mounting cavity. The atomizer includes: an atomizer shell, a liquid storage chamber, a liquid storage chamber cover, a detachable liquid receiving cup, a covered heating and cooling regulating tube, an ultrasonic atomizing plate, a mist guide plate, and a mist outlet cover. The upper front part of the atomizer shell forms a liquid storage chamber assembly cavity, the lower front part of the atomizer shell forms a liquid receiving cup assembly cavity, and the middle rear part of the atomizer shell forms an atomizing cavity. The covered heating and cooling regulating tube and the ultrasonic atomizing plate are installed in the atomizing cavity, the liquid storage chamber is assembled in the liquid storage chamber assembly cavity, and the liquid outlet of the liquid storage chamber is connected to the ultrasonic atomizer. On the left side of the atomizer, the inlet of the encapsulated heating and cooling regulating tube connects to the right side of the ultrasonic atomizing plate. The lower section of the mist flow guide plate is rotatably or swingably mounted at the middle position of the outlet of the encapsulated heating and cooling regulating tube, and the upper section of the mist flow guide plate extends above the encapsulated heating and cooling regulating tube. The rear part of the atomizer housing is mounted into the mounting cavity. The outlet of the encapsulated heating and cooling regulating tube extends out of the atomizing hole, and the top of the mist flow guide plate extends out of the operating hole. The mist outlet cover is mounted on the outlet of the encapsulated heating and cooling regulating tube, and the mist outlet through holes on the left and right sides of the mist outlet cover are separated on both sides of the mist flow guide plate. The detachable liquid receiving cup is installed into the liquid receiving cup mounting cavity, and the liquid collection channel of the encapsulated heating and cooling regulating tube extends forward and downward and connects to the detachable liquid receiving cup.

[0010] In the split-type atomizing eye mask described above, preferably, a soft fitting component is connected to the edge of the eye mask body, and eye mask back straps are connected to both ends of the eye mask body.

[0011] As described above, in the split-type atomizing goggles, preferably, the atomizer housing includes a front housing, a middle partition, and a rear housing, and the liquid storage chamber includes a front chamber and a rear chamber. The atomizing chamber is located inside the rear housing. After the encapsulated heating and cooling regulating tube and the ultrasonic atomizing plate are installed inside the atomizing chamber, the rear side of the middle partition is connected to the front end of the rear housing, the rear end of the rear chamber is connected to the front side of the middle partition, the rear end of the front chamber is connected to the front end of the rear chamber, the upper circumferential surface of the front housing is connected to the lower circumferential surface of the front chamber, and the upper inner circumferential surface of the front housing is connected to the outer circumferential surface of the front chamber.

[0012] In the split-type atomizing goggles described above, preferably, the space between the upper part of the front shell and the middle partition is a liquid storage tank assembly cavity, the space between the lower part of the front shell and the rear shell is a liquid receiving cup assembly cavity, and the middle part of the front shell separates the liquid storage tank assembly cavity and the liquid receiving cup assembly cavity.

[0013] As described above, the split-type atomizing goggles preferably include an enclosed temperature regulating tube comprising: a liquid collection channel, an outer tube, a partition tube, a cooling semiconductor, and a heating element; wherein the upper end of the liquid collection channel is connected to the bottom of the outer tube, the partition tube is disposed inside the outer tube and there is a gap between the partition tube and the outer tube, the cooling semiconductor is arranged around the gap between the partition tube and the outer tube, and the heating element is attached to the inner side of the partition tube.

[0014] In the split-type atomizing goggles described above, preferably, the lower section of the mist flow guide plate is a flow guide plate, and the upper section of the mist flow guide plate is a connecting rod and an operating disc; wherein, the lower end of the connecting rod is connected to the upper end of the flow guide plate, the upper end of the connecting rod is connected to the lower end of the operating disc, and the circumference of the operating disc has an operating protrusion protruding rearward, the operating protrusion extending out of the operating hole.

[0015] An adaptive nebulization care system for a split-type nebulizing goggle mask includes: a pressure sensor, an optical sensor, a setting input module, and an electronic control module. The pressure sensor is located on the bottom or side wall of the liquid reservoir, the optical sensor is located on the side wall of the liquid reservoir, the setting input module is mounted on the nebulizer housing, and the electronic control module is located inside the nebulizer housing, outside the liquid reservoir assembly cavity, the liquid receiving cup assembly cavity, and the nebulization chamber. The pressure sensor detects the liquid pressure in the liquid reservoir and transmits it to the electronic control module. The optical sensor detects the light transmittance and refraction angle of the liquid in the liquid reservoir and transmits them to the electronic control module. The setting input module detects the preset care duration or current nebulization rate input by the user and transmits it to the electronic control module. The electronic control module runs a liquid parameter database, and uses a mapping table of remaining liquid volume in the liquid parameter database to represent the liquid pressure. The system queries the curve to obtain the remaining amount of medication in the storage tank. It then queries the medication concentration mapping table / curve in the medication parameter database using the medication transmittance and refraction angle to determine the medication concentration. The electronic control module has a preset nebulization parameter database. It queries the nebulization parameter back-calculation mapping table / curve in the database using the remaining medication amount and concentration to obtain the optimal nebulization rate, nebulization power, and optimal care time. Alternatively, it queries the preset care time, remaining medication amount, and medication concentration in the database to obtain the optimal nebulization rate and power, or the current nebulization rate, remaining medication amount, and medication concentration to obtain the optimal care time. Finally, it issues nebulization commands based on the optimal nebulization rate, power, and time.

[0016] The adaptive nebulization nursing system of the split-type nebulizing goggles described above preferably constructs a nebulization parameter back-mapping table / curve through the mapping relationship between medication parameters, optimal nebulization rate, nebulization power, and optimal nursing time. The steps for obtaining the mapping relationship between medication parameters, optimal nebulization rate, nebulization power, and optimal nursing time are as follows: Step S11: Calculate the effective medication volume required to complete the nursing by combining the medication concentration with the introduced medication time-effect decay coefficient; Step S12: Calculate the optimal nebulization rate by combining the medication concentration with ambient temperature and humidity, and calculate the nebulization power by combining the optimal nebulization rate with the medication concentration and ambient temperature; Step S13: Calculate the optimal nursing time based on the optimal nebulization rate, effective medication volume, remaining medication volume, and rated capacity of the storage tank.

[0017] The adaptive nebulization nursing system of the split-type nebulizing goggles described above preferably constructs a nebulization parameter back-mapping mapping table / curve through the mapping relationship between preset nursing time, medication parameters, optimal nebulization rate, and nebulization power. The steps for obtaining the mapping relationship between preset nursing time, medication parameters, optimal nebulization rate, and nebulization power are as follows: Step S21: Combine the remaining medication volume with the introduced medication time-effect decay coefficient to determine the maximum nebulizable medication volume within the preset nursing time; Step S22: Based on the maximum nebulizable medication volume and the preset nursing time, initially calculate the basic nebulization rate, and then perform a first correction based on ambient temperature and humidity to obtain the first-correction nebulization rate; Step S23: Calculate the medication viscosity using the medication transmittance, and then perform a second correction based on the medication concentration to obtain the second-correction nebulization rate; Step S24: Introduce user self-learning correction to perform a final correction on the second-correction nebulization rate to obtain the optimal nebulization rate, and calculate the nebulization power by combining the optimal nebulization rate with medication concentration and ambient temperature.

[0018] The adaptive nebulization nursing system for the split-type nebulizing goggles described above preferably constructs a nebulization parameter back-mapping table / curve through the mapping relationship between the current nebulization rate and the medication parameters-optimal nursing time. The steps for obtaining the mapping relationship between the current nebulization rate and the medication parameters-optimal nursing time are as follows: Step S31: Considering the nebulization efficiency decay at the current nebulization rate, calculate the longest nebulization time supported by the remaining medication volume; Step S32: Combine the medication concentration with the introduced medication time-effect decay coefficient to calculate the effective medication volume required to complete the nursing care; Step S33: Based on the effective medication volume, combined with the medication concentration, ambient temperature, and current nebulization rate, calculate the shortest nebulization time required to achieve the effective nursing dosage; Step S34: Calculate the environmental comfort coefficient by coupling ambient temperature and humidity, and then combine it with the user's nursing comfort weight, the longest nebulization time, and the shortest nebulization time to calculate the optimal nursing time.

[0019] Beneficial effects: 1. Improve drug utilization rate

[0020] After the condensate is collected by a detachable receiving cup, it can be manually transferred into the storage tank for reuse, reducing waste of the medicine and improving the overall utilization efficiency of the medicine.

[0021] 2. Enhance the stability of atomization effect The mist distribution deflector enables single-source, split-flow left and right mist volume adjustment, allowing the mist volume around the eyes to be adjusted according to the user's needs, thus providing a more targeted care experience.

[0022] 3. Improve the ease of cleaning and maintenance. The split-type atomizing chamber design allows users to easily disassemble the internal components for cleaning, avoiding the cleaning difficulties and potential drug residue issues associated with traditional integrated designs. Furthermore, the modular structure allows for independent replacement and repair of each component, reducing equipment maintenance costs and extending the product's long-term lifespan.

[0023] 4. Improves eye comfort and temperature control. The enclosed heating and cooling regulating tube can effectively improve heat exchange efficiency, allowing the mist to be heated or cooled before output, ensuring that the mist temperature is suitable and more evenly distributed, avoiding the interference of traditional temperature control methods on the atomization effect, and also improving the user's comfort.

[0024] 5. Enhance structural reliability and system integrity The liquid storage tank and the detachable liquid receiving cup are physically isolated, avoiding the complexity and risks associated with an automatic reflux structure. At the same time, the functions of each module are clearly defined, making the overall equipment more complete in terms of structure and control logic, and giving it strong technical advantages and application value.

[0025] 6. Enhance the intelligence and adaptability of atomization control. By establishing a linkage and reverse control relationship between drug solution parameters, atomization rate, and nursing time, the equipment can automatically match nursing parameters based on drug concentration, light transmittance, liquid storage status, and user-set conditions. Compared with the traditional fixed atomization mode, it can automatically adjust a more suitable atomization rate or nursing time under different drugs, different liquid volumes, and different nursing scenarios, thereby improving the consistency, scientific nature, and ease of use of the nursing process. Attached Figure Description

[0026] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For those skilled in the art, other drawings can be obtained based on these drawings.

[0027] Figure 1 This is a 3D view of the front of a split-type atomizing eye mask; Figure 2 This is a 3D view of the back of the split-type atomizing eye mask; Figure 3 This is a 3D diagram showing the disassembled design of a split-type atomizing eye mask; Figure 4 This is a split-type atomizing eye mask front view; Figure 5 This is a 3D diagram of the atomizer in a split-type atomizing eye mask; Figure 6 This is a cross-sectional view of the atomizer in a split-type atomizing eye mask; Figure 7 This is a schematic diagram of the enclosed temperature regulation tube of a split-type atomizing eye mask; Figure 8 This is a side view of the mist flow guide plate and mist outlet cover of the atomizer of the split-type atomizing goggles; Figure 9 This is a front view of the mist guide plate and mist outlet cover of the atomizer of the split-type atomizing goggles; Figure 10 This is a schematic diagram of an adaptive atomization care system for split-type atomizing eye masks; Figure 11 This is a flowchart of the first method executed by the electronic control module of the adaptive nebulization care system; Figure 12 This is a flowchart of the second method executed by the electronic control module of the adaptive nebulization care system; Figure 13 This is a flowchart of the third method executed by the electronic control module of the adaptive nebulizer nursing system. Detailed Implementation

[0028] Embodiments of the present invention are described in detail below. Examples of these embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals denote the same or similar elements or elements having the same or similar functions throughout. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and should not be construed as limiting the present invention.

[0029] like Figures 1 to 4As shown, this application provides a split-type atomizing eye mask, including: an eye mask body 10 and an atomizer 20; wherein, the eye mask body 10 has two blocking parts corresponding to the user's left eye area and right eye area, the part between the two blocking parts of the eye mask body 10 is recessed inward to form a mounting cavity 11, the middle part of the mounting cavity 11 is provided with an atomizing hole 111 that passes through the inside and outside, and the top of the mounting cavity 11 is provided with an operating hole 112 that passes through the inside and outside. The "lens" here may not be a real lens, but only the part of the eye mask body 10 located in front of the user's eyes after being worn on the user's head.

[0030] Optionally, a soft-fitting component 30 is connected to the edge of the eye mask body 10, allowing for a more comfortable and snug fit to the user's face; eye mask back straps 40 are connected to both ends of the eye mask body 10 for easy attachment of the separate atomizing eye mask to the user's head. Alternatively, the eye mask body 10 is made of plastic, and the soft-fitting component 30 is made of silicone, with the soft-fitting component 30 detachably connected to the eye mask body 10 for easy replacement. Another option is that the top of the mounting cavity 11 protrudes upwards, so that the position of the operating hole 112 is higher than the edge of the eye mask body 10 for easy operation. Still optional, the orientation of the operating hole 112 is the same as the orientation of the soft-fitting component 30, so that the operating hole 112 faces the user for easy operation.

[0031] like Figure 5 and Figure 6 As shown, the atomizer 20 includes: an atomizer housing 21, a liquid storage chamber 22, a liquid storage chamber cover 23, a detachable liquid receiving cup 24, a wrap-around hot and cold regulating tube 25, an ultrasonic atomizing plate 26, a mist flow guide plate 27, and a mist outlet cover plate 28; wherein, the upper front part of the atomizer housing 21 forms a liquid storage chamber assembly cavity, the lower front part of the atomizer housing 21 forms a liquid receiving cup assembly cavity, and the middle rear part of the atomizer housing 21 forms an atomizing cavity.

[0032] The encapsulated heating and cooling regulating tube 25 and the ultrasonic atomizing plate 26 are installed in the atomization chamber. The liquid storage chamber 22 is assembled in the liquid storage chamber assembly chamber, and the liquid outlet of the liquid storage chamber 22 is connected to the left side of the ultrasonic atomizing plate 26. The mist inlet of the encapsulated heating and cooling regulating tube 25 is connected to the right side of the ultrasonic atomizing plate 26. Thus, the liquid medicine in the liquid storage chamber 22 flows out from its liquid outlet and is atomized into mist by the ultrasonic atomizing plate 26. The mist then enters the encapsulated heating and cooling regulating tube 25 through the mist inlet.

[0033] The lower section of the mist guide plate 27 is rotatably or swingably mounted at the mist outlet of the enclosed heating and cooling regulating tube 25, and the upper section of the mist guide plate 27 extends above the enclosed heating and cooling regulating tube 25; the rear part of the atomizer housing 21 is mounted into the mounting cavity 11, the mist outlet of the enclosed heating and cooling regulating tube 25 extends out of the atomizing hole 111, and the top of the mist guide plate 27 extends out of the operating hole 112; the mist outlet cover plate 28 is mounted from the inside of the goggle body 10 to the mist outlet of the enclosed heating and cooling regulating tube 25, and both sides of the mist outlet cover plate 28 are provided with... The two mist outlet holes 281 are separated on both sides of the mist flow guide plate 27. That is, the mist flow guide plate 27 is located between the mist outlet holes 281 on the left and right sides. By operating the top of the mist flow guide plate 27, the lower section of the mist flow guide plate 27 can be rotated or oscillated left and right. By changing the deflection angle of the mist flow guide plate 27 relative to the mist outlet holes 281 on the left and right sides, the proportion of mist sprayed from the two mist outlet holes 281 on the left and right sides can be adjusted, thereby providing different amounts of atomization to the user's left and right eye areas.

[0034] The detachable receiving cup 24 is detachably installed into the receiving cup assembly cavity. The liquid collection channel 251 of the enclosed temperature regulating tube 25 extends forward and downward and connects to the detachable receiving cup 24, so that the liquid at the bottom of the enclosed temperature regulating tube 25 is collected into the detachable receiving cup 24 through the liquid collection channel 251. The top of the liquid storage chamber 22 is provided with a liquid filling port. The liquid storage chamber cover 23 is installed on the top of the liquid storage chamber 22 to seal the liquid filling port. After a certain amount of liquid is collected in the detachable receiving cup 24, the detachable receiving cup 24 is removed from the atomizer housing 21. Then, the liquid in the detachable receiving cup 24 is poured into the liquid storage chamber 22 through the liquid filling port to realize the reuse of the liquid.

[0035] Optionally, the rear part of the atomizer housing 21 and the mounting cavity 11 of the goggle body 10 can be assembled and disassembled through a magnetic attraction structure, thereby enabling quick assembly and disassembly of the atomizer housing 21 and the mounting cavity 11 of the goggle body 10. Optionally, the atomizer housing 21 includes a front housing 211, a middle partition 212, and a rear housing 213, and the liquid storage chamber 22 includes a front chamber 222 and a rear chamber 221. The atomizing chamber is located inside the rear housing 213. After the encapsulated heating and cooling regulating tube 25 and the ultrasonic atomizing plate 26 are installed in the atomizing chamber, the rear side of the middle partition 212 is connected to the front end of the rear housing 213, the rear end of the rear chamber 221 is connected to the front side of the middle partition 212, the rear end of the front chamber 222 is connected to the front end of the rear chamber 221, and finally the upper circumferential surface of the front housing 211 is connected to the lower circumferential surface of the front chamber 222, and the upper inner circumferential surface of the front housing 211 is connected to the outer circumferential surface of the front chamber 222, thereby completing the assembly of the encapsulated heating and cooling regulating tube 25, the ultrasonic atomizing plate 26, the atomizer housing 21, and the liquid storage chamber 22. Optionally, the space between the upper part of the front shell 211 and the middle partition 212 is a liquid storage tank assembly cavity, and the space between the lower part of the front shell 211 and the rear shell 213 is a liquid receiving cup assembly cavity. The middle part of the front shell 211 separates the liquid storage tank assembly cavity and the liquid receiving cup assembly cavity, thereby physically isolating the liquid storage tank 22 from the detachable liquid receiving cup 24. Still optional, the connections between the middle partition 212 and the rear shell 213, the connection between the rear compartment 221 and the middle partition 212, the connection between the front compartment 222 and the rear compartment 221, and the connection between the front shell 211 and the front compartment 222 are all detachable connections, such as snap-fit ​​connections. Alternatively, the detachable liquid receiving cup 24 is snap-fitted into the liquid receiving cup assembly cavity from bottom to top.

[0036] This application utilizes a detachable design (removing the mist outlet cover 28 from the mist outlet of the enclosed heating and cooling regulating tube 25, removing the rear part of the atomizer housing 21 from the mounting cavity 11 of the goggle body 10, and removing the mist flow guide plate 27 from the mist outlet of the enclosed heating and cooling regulating tube 25) to more thoroughly clean the ultrasonic atomizing plate 26 inside the atomizing chamber, avoiding problems such as liquid residue and clogging. Simultaneously, the modular design allows for individual replacement of each component, reducing the maintenance cost of the atomizing goggle and extending its service life. In addition, by setting a detachable liquid receiving cup 24 at the lower front of the enclosed heat and cold regulating pipe 25, the condensed medicine formed by the condensation of mist can be collected, so that the condensed medicine will no longer remain disorderly inside the cover, which is conducive to improving the internal environment after use. Furthermore, the liquid storage chamber 22 and the detachable liquid receiving cup 24 are physically isolated to prevent the original medicine from mixing with the condensed medicine. After the original medicine is used up, the condensed medicine can be manually removed from the detachable liquid receiving cup 24 and introduced into the liquid storage chamber 22, which can reduce the waste of medicine and achieve efficient utilization of medicine.

[0037] like Figure 7 As shown, the enclosed heating and cooling regulating tube 25 includes: a liquid collection channel 251, an outer tube 252, a partition tube 253, a cooling semiconductor 254, and a heating element 255; wherein, the upper end of the liquid collection channel 251 is connected to the bottom of the outer tube 252 to facilitate the collection of condensed liquid at the bottom of the outer tube 252 into a detachable liquid receiving cup 24; the partition tube 253 is disposed inside the outer tube 252, and there is a gap between the partition tube 253 and the outer tube 252; the cooling semiconductor 254 is arranged around the gap between the partition tube 253 and the outer tube 252; and the heating element 255 is attached to the inner side of the partition tube 253.

[0038] In the warm fog care mode, when the fog passes through the enclosed heating and cooling regulating tube 25, the heating element 255 inside the partition tube 253 can heat the fog; in the cold fog care mode, when the fog passes through the enclosed heating and cooling regulating tube 25, the cooling semiconductor 254 between the partition tube 253 and the outer tube body 252 can cool the fog. Because the separator tube 253 has a hollow cylindrical structure, and the heating element 255 surrounds the inner side of the separator tube 253 and the cooling semiconductor 254 surrounds the outer side of the separator tube 253, the heat exchange area between the mist and the heating element 255 or the cooling semiconductor 254 is increased, so that the mist can be heated or cooled evenly during the output process, reducing heat loss. In addition, the heating element 255 and the cooling semiconductor 254 used for temperature control are separated from the vibration area of ​​the ultrasonic atomizing plate 26, thereby reducing the impact of the heating element 255 and the cooling semiconductor 254 used for temperature control on the working stability of the ultrasonic atomizing plate 26. Furthermore, by superimposing the heating element 255 and the cooling semiconductor 254, the normal temperature mist care, warm mist care, or cold mist care modes can be switched in different care scenarios, improving the application breadth of the split-type atomizing goggles.

[0039] Optionally, the liquid collection channel 251 and the outer tube 252 are an integral structure. Alternatively, the upper end of the liquid collection channel 251 is connected to the bottom of the outer tube 252 near the front end. Still optional, the separator tube 253 is an injection-molded tube. Again optional, multiple cooling semiconductors 254 are evenly distributed circumferentially on the outer side of the separator tube 253, and heating elements 255 are circumferentially attached to the inner side of the separator tube 253. Alternatively, the hot end of the cooling semiconductor 254 can be connected to a heat-conducting component, a heat sink, a metal heat-conducting ring, or the heat-conducting area of ​​the atomizer housing to conduct heat to the outside of the atomizer or the heat dissipation area of ​​the housing.

[0040] like Figure 8 and Figure 9As shown, the lower section of the mist guide plate 27 is the guide plate 271, and the upper section of the mist guide plate 27 is the connecting rod 272 and the operating panel 273. The lower end of the connecting rod 272 is connected to the upper end of the guide plate 271, and the upper end of the connecting rod 272 is connected to the lower end of the operating panel 273. When the guide plate 271 deflects to the left, more mist is directed to the mist outlet 281 on the right side. When the guide plate 271 deflects to the right, more mist is directed to the mist outlet 281 on the left side. This allows for dynamic adjustment of the mist output on both sides. Therefore, when symptoms around the eyes are more pronounced on one side, the mist output on the corresponding side can be increased by adjusting the mist guide plate 27, thereby improving user comfort and targeted care.

[0041] Optionally, the deflector 271 is a triangular prism, with its front edge facing forward and its rear side facing backward. The lower end of the connecting rod 272 is connected to the upper end of the deflector 271 near the rear side, which facilitates the left-right swinging of the deflector 271 and thus facilitates the guidance of mist by the left and right sides of the deflector 271. Alternatively, the deflector 271 is an isosceles triangular prism, with equal areas on its left and right sides, ensuring equal adjustment standards for mist on both sides, making mist guidance simple and convenient. Still alternatively, the areas of the left and right sides of the deflector 271 are larger than the rear side, resulting in a flatter shape for the deflector 271 and preventing it from occupying excessive space. Alternatively, to facilitate the extension of part of the operation disk 273 out of the operation hole 112, an operation protrusion is provided on the circumference of the operation disk 273. The operation protrusion extends out of the operation hole 112. By moving the operation protrusion, the operation disk 273 is rotated, thereby causing the guide plate 271 to swing left and right through the connecting rod 272.

[0042] To ensure the stability of the mist guide plate 27, a positioning rod 274 is connected to the lower end of the guide plate 271. Semicircular holes are provided at the upper and lower positions of the circumference of the mist cover plate 28, and semicircular holes are also provided at the upper and lower positions of the mist outlet of the enclosed heating and cooling pipe 25. The positioning rod 274 is surrounded by the semicircular hole at the lower position of the circumference of the mist cover plate 28 and the semicircular hole at the lower position of the mist outlet of the enclosed heating and cooling pipe 25. The connecting rod 272 is surrounded by the semicircular hole at the upper position of the circumference of the mist cover plate 28 and the semicircular hole at the upper position of the mist outlet of the enclosed heating and cooling pipe 25.

[0043] In this application, by adjusting the angle of the mist guide plate 27, the deflection direction of the mist after impacting the mist guide plate 27 and the flow distribution ratio of the two mist outlet holes 281 on the left and right sides are changed. Thus, the output of the mist volume of the two mist outlet holes 281 on the left or right sides can be increased as needed. Therefore, this application can meet the personalized care needs by using only a single ultrasonic atomizing plate 26 as the mist source. Compared with a completely independent dual air path structure, this application achieves left and right mist volume adjustment while maintaining a single mist source and a single main airflow channel, thus reducing the structural complexity.

[0044] like Figure 10 As shown, this application provides an adaptive nebulization care system for a split-type nebulizing goggle, applied in the aforementioned split-type nebulizing goggle, including: a pressure sensor 50, an optical sensor 60, a setting input module 70, and an electronic control module 80; wherein, the pressure sensor 50 is disposed on the bottom wall or side wall of the liquid storage chamber 22, and the optical sensor 60 is disposed on the side wall of the liquid storage chamber 22. The installation positions of the pressure sensor 50 and the optical sensor 60 can ensure that they can capture the dynamic changes of the liquid during nebulization in real time, reducing detection delay; the setting input module 70 is installed on the nebulizer housing 21, and is used by the user to input the preset care duration or the current nebulization rate; the electronic control module 80 is disposed inside the nebulizer housing 21, and is located outside the liquid storage chamber assembly cavity, the liquid receiving cup assembly cavity, and the nebulization chamber, thereby effectively isolating the condensed liquid, leaked liquid, and other moisture factors generated during nebulization, providing a dry and stable working environment for the electronic control module 80, preventing signal disorder and component damage caused by moisture, and ensuring the stable operation of the control logic.

[0045] Optionally, a liquid pressure detection chamber (not shown in the figure) is connected to the bottom or side wall of the liquid storage tank 22. The opening of the liquid pressure detection chamber is sealed by a diaphragm, elastic sheet, or sealing pressure transmission structure. The pressure sensor 50 is disposed in the liquid pressure detection chamber, and the pressure sensor 50 can sense the pressure change of the liquid in the liquid storage tank 22 through the diaphragm, elastic sheet, or sealing pressure transmission structure, avoiding the pressure sensor 50 being directly disposed in the liquid storage tank 22 and blocking the flow of the liquid to the channel or covering the ultrasonic atomizing sheet 26. Alternatively, detection channels (not shown in the figure) are connected to the opposite side walls of the liquid storage tank 22, and the openings of the detection channels are sealed by transparent detection windows. The optical sensor 60 includes a light-emitting end and a receiving end, which are respectively disposed in the detection channels located on both sides, and are used to detect the transmittance, refraction angle, light intensity attenuation, or other optical change parameters of the liquid in the liquid storage tank 22.

[0046] Pressure sensor 50 detects the pressure of the medicine liquid in the storage tank 22 and transmits the medicine liquid pressure to electronic control module 80. Optical sensor 60 detects the light transmittance and refraction angle of the medicine liquid in the storage tank 22 and transmits the light transmittance and refraction angle of the medicine liquid to electronic control module 80. Setting input module 70 detects the preset nursing duration or current mist rate input by the user and transmits the preset nursing duration or current mist rate to electronic control module 80.

[0047] The electronic control module 80 operates a liquid medicine parameter database. After receiving the liquid medicine pressure, transmittance, and refraction angle, the electronic control module 80 queries the liquid medicine remaining quantity mapping table / curve in the liquid medicine parameter database to obtain the remaining quantity of liquid medicine in the storage tank 22. It then queries the liquid medicine concentration mapping table / curve in the liquid medicine parameter database to obtain the concentration of liquid medicine in the storage tank 22 using the transmittance and refraction angle. By adopting a dual-mode detection principle of transmission and refraction, interference from bubbles and impurities in the liquid medicine on the detection results can be eliminated, thereby improving the accuracy of liquid medicine concentration detection.

[0048] The remaining amount of medication mapping table / curve and the medication concentration mapping table / curve are pre-built. The product only needs to store the remaining amount of medication mapping table / curve and the medication concentration mapping table / curve in the medication parameter database. In this way, the electronic control module 80 only needs to perform a query operation during adaptive nebulization care. As a result, the electronic control module 80 in the product does not need to have a large computing power, which is more in line with the needs of the split-type nebulization eye mask.

[0049] Furthermore, a mapping table / curve for the remaining liquid medicine is constructed based on the mapping relationship between the remaining liquid medicine volume and the hydraulic pressure. The mapping relationship between the remaining liquid medicine volume and the hydraulic pressure is shown in the following formula: ; in, This refers to the remaining amount of the medicine solution; The shape correction coefficient for the liquid storage tank is preset according to the shape of the liquid storage tank to correct the nonlinear deviation between the liquid level height and the liquid volume. The cross-sectional area of ​​the liquid storage tank is the internal cross-sectional area. Changes with liquid level; The pressure of the liquid medicine; The density of the liquid medicine at a standard temperature (e.g., 25°C); The coefficient of thermal expansion of the liquid medicine is a fixed value corresponding to different liquid medicines, which is stored in the electronic control module; The difference between the current liquid temperature and the standard liquid temperature (e.g., 25°C) can be detected in real time by an added temperature sensor, which can be installed in the liquid storage chamber 22 near the ultrasonic atomizing plate 26. This is the acceleration due to gravity.

[0050] Furthermore, a drug concentration mapping table / curve is constructed by mapping the drug concentration, drug transmittance, and drug refraction angle. The mapping relationship between drug concentration, drug transmittance, and drug refraction angle is shown in the following formula: ; in, This refers to the concentration of the drug solution. The fusion weighting coefficient ranges from 0.6 to 0.8 and is dynamically adjusted by the electronic control module based on the signal-to-noise ratio of the detected signal. The higher the signal-to-noise ratio, the larger the fusion weighting coefficient. The transmittance of the drug solution ranges from 0 to 1. The molar absorptivity of the drug solution is a fixed value corresponding to different drug solutions, which is stored in the electronic control module. The optical path length is the thickness of the light-transmitting area of ​​the liquid storage tank, an inherent parameter of the equipment. The refractive index of the drug solution, ; The refractive index of air is 1.0003. The incident light angle is a parameter inherent to the device, taken as 45°. The angle of refraction of the liquid; This is the refractive index-concentration correlation coefficient of the drug solution. Different drug solutions correspond to different fixed values, which are stored in the electronic control module.

[0051] The sub-control module 80 has a preset nebulization parameter database. After obtaining the remaining amount and concentration of the medication, the electronic control module 80 queries the nebulization parameter back-mapping mapping table / curve in the nebulization parameter database to obtain the optimal nebulization rate, nebulization power, and optimal care time. Alternatively, the electronic control module 80 queries the nebulization parameter back-mapping mapping table / curve in the nebulization parameter database using the preset care time, remaining amount and concentration of the medication to obtain the optimal nebulization rate and nebulization power. Or, the electronic control module 80 queries the nebulization parameter back-mapping mapping table / curve in the nebulization parameter database using the current nebulization rate, remaining amount and concentration of the medication to obtain the optimal care time. Based on the optimal nebulization rate, nebulization power, and optimal care time, the electronic control module 80 issues a nebulization command to dynamically adjust the nebulization output of the split-type nebulizing goggles, enabling the split-type nebulizing goggles to have adaptive care capabilities based on dual feedback.

[0052] The atomization parameter reverse mapping table / curve is pre-built. The product only needs to store the atomization parameter reverse mapping table / curve in the atomization parameter database. In this way, the electronic control module 80 only needs to perform a query operation during adaptive atomization care. As a result, the electronic control module 80 in the product does not need to have a large computing power, which is more in line with the needs of the split atomization eye mask.

[0053] The nebulization parameter back-mapping tables / curves (drug solution parameter back-mapping tables / curves, preset nursing time back-mapping tables / curves, and drug solution parameter and current nebulization rate back-mapping tables / curves) of this application are obtained through the following three methods: The first method involves constructing a reverse mapping table / curve for drug solution parameters by establishing a mapping relationship between drug solution parameters, optimal nebulization rate, nebulization power, and optimal treatment time. After calculating the concentration and remaining amount of the medication, the system combines ambient temperature and humidity with the medication's time-dependent decay coefficient to automatically calculate the optimal atomization rate, atomization power, and optimal care time. This enables precise matching of medication characteristics, environmental conditions, and atomization output, ensuring that the medication is used to complete the care process under optimal output conditions and avoiding medication waste, insufficient care effects, or atomization failure caused by environmental factors.

[0054] Specifically, such as Figure 11 As shown, the steps for obtaining the mapping relationship between drug solution parameters, optimal nebulization rate, nebulization power, and optimal care time are as follows: Step S11: Combine the drug concentration with the introduced drug time-effect decay coefficient to calculate the effective drug volume required to complete the nursing care. The formula for calculating the effective drug volume is as follows: ; in, The effective volume of the drug solution; The effective dosage of a medicated solution refers to the minimum mass of pure active ingredients in the medicated solution required to achieve the preset nursing effect, and can be dynamically matched according to the type of medicated solution. This is the time-dependent decay coefficient of the drug solution, with different fixed values ​​corresponding to different drug solutions; This refers to the duration of time the liquid medicine is placed in the storage tank.

[0055] Determine the effective drug volume With the remaining amount of medicine If the relationship, If so, continue with the following steps, if If the medication solution is insufficient, the system will automatically adjust the effective medication solution volume required to complete the treatment (e.g., by proportional reduction) and then continue with the following steps.

[0056] Step S12: Calculate the optimal atomization rate by combining the drug concentration with the ambient temperature and humidity, and calculate the atomization power by combining the optimal atomization rate with the drug concentration and ambient temperature. The formulas for calculating the optimal atomization rate and atomization power are as follows: ; ; in, For optimal atomization rate; The calibration coefficient has different values ​​for different solutions and can be dynamically updated through a self-learning algorithm. This is the temperature compensation coefficient, with a value ranging from 0.01 to 0.03. Ambient temperature; This is the humidity compensation coefficient, with a value ranging from 0.005 to 0.01. For ambient humidity; This refers to the atomization power.

[0057] Step S13: Calculate the optimal nursing time based on the optimal atomization rate, effective drug volume, remaining drug volume, and rated capacity of the storage tank. The formula for calculating the optimal nursing time is as follows: ; in, This is the optimal time for care; This is the liquid volume correction factor, preset to 0.1~0.2; The rated capacity of the liquid storage tank.

[0058] The second method involves constructing a back-calculation mapping table / curve for preset nursing time by establishing a mapping relationship between preset nursing time and medication parameters—optimal nebulization rate and nebulization power. When the user inputs a preset care time (e.g., 10 minutes, 15 minutes, or other durations), and the drug concentration and remaining amount are calculated, the system automatically calculates the optimal nebulization rate and power by taking into account ambient temperature and humidity, drug efficacy attenuation coefficient, and user's historical nebulization rate adjustment deviation. This enables precise matching of drug characteristics, environmental conditions, and nebulization output, ensuring stable and continuous nebulization of the drug within the preset care time, maximizing the nebulization of all effective drugs, reducing waste, and aligning with user habits.

[0059] Specifically, such as Figure 12 As shown, the steps to obtain the mapping relationship between preset nursing time and drug solution parameters, optimal nebulization rate, and nebulization power are as follows: Step S21: Combine the remaining amount of medication with the introduced medication time-effect decay coefficient to determine the maximum volume of medication that can be atomized within the preset nursing time. The formula for calculating the maximum volume of liquid medicine that can be atomized is as follows: ; in, This represents the maximum volume of liquid medicine that can be atomized. This is the time-dependent decay coefficient of the drug solution, with different fixed values ​​corresponding to different drug solutions; This refers to the duration of time the liquid medicine is placed in the storage tank.

[0060] Step S22: Based on the maximum volume of atomizable liquid and the preset nursing time, calculate the basic atomization rate initially, and then make the first correction to the basic atomization rate by combining the ambient temperature and humidity to obtain the first correction atomization rate. The formulas for calculating the basic atomization rate and the first-stage atomization rate are as follows: ; ; in, Basic atomization rate; Preset nursing time; To improve the atomization rate; This is the temperature compensation coefficient, with a value ranging from 0.01 to 0.03. Ambient temperature; This is the humidity compensation coefficient, with a value ranging from 0.005 to 0.01. This refers to ambient humidity.

[0061] Step S23: Calculate the viscosity of the drug solution by the transmittance of the drug solution, and then make a second correction to the atomization rate of the first repair by combining the drug solution concentration to obtain the atomization rate of the second repair. The formula for calculating the atomization rate of the second repair is as follows: ; ; in, The viscosity of the drug solution; This is the viscosity calibration coefficient; The transmittance of the drug solution ranges from 0 to 1. For the second repair of atomization rate; This is the viscosity correction factor, preset to 0.05~0.1; This is the concentration correction factor, preset to 0.1~0.3; This refers to the concentration of the drug solution at a standard temperature (e.g., 25°C).

[0062] Step S24: Introduce user self-learning correction to make final correction to the atomization rate of the second repair, obtain the optimal atomization rate, and calculate the atomization power by combining the optimal atomization rate with the drug concentration and ambient temperature. The formulas for calculating the optimal atomization rate and atomization power are as follows: ; ; in, The user preference weight is set at 0.2 to 0.4 and is dynamically adjusted based on the frequency of user usage. The historical atomization rate adjustment deviation is the average difference between the manually adjusted atomization rate and the optimal atomization rate calculated by the electronic control module during the user's historical usage.

[0063] The third method involves constructing a mapping table / curve between the current nebulization rate and the medication parameters and the optimal care time, using the mapping relationship between the current nebulization rate and the medication parameters and the optimal care time. When the state of the medication solution is known and the current atomization rate is known, after calculating the medication concentration and remaining amount, the system combines ambient temperature and humidity with the medication's time-dependent decay coefficient to automatically calculate the optimal nursing time. This enables the system to provide users with recommended nursing durations, thereby improving the scientific nature and adaptability of the nursing process.

[0064] Specifically, such as Figure 13 As shown, the steps to obtain the mapping relationship between the current nebulization rate and the medication parameters and the optimal care time are as follows: Step S31: Under the current atomization rate, after considering the decay of atomization efficiency, calculate the longest atomization time that the remaining amount of medicine can support; The formula for calculating the longest nebulization time supported by the remaining liquid is as follows: ; ; in, This represents the current atomization efficiency of the ultrasonic atomizing plate. The initial atomization efficiency of the ultrasonic atomizing plate is preset to 0.8~0.9; The atomization efficiency attenuation coefficient is preset to 0.005~0.01; This refers to the cumulative working time of the ultrasonic atomizing plate. This is the longest atomization time for the ultrasonic atomizing plate; This is the time-dependent decay coefficient of the drug solution, with different fixed values ​​corresponding to different drug solutions; This refers to the duration of time the liquid medicine is placed in the storage tank. This represents the current atomization rate.

[0065] Step S32: Combine the drug concentration with the introduced drug time-effect decay coefficient to calculate the effective drug volume required to complete the nursing care; The formula for calculating the effective drug volume is as follows: ; in, The effective volume of the drug solution; The effective dosage of a medicated solution refers to the minimum mass of pure active ingredients in the medicated solution required to achieve the preset nursing effect, and can be dynamically matched according to the type of medicated solution. This is the time-dependent decay coefficient of the drug solution, with different fixed values ​​corresponding to different drug solutions; This refers to the duration of time the liquid medicine is placed in the storage tank.

[0066] Step S33: Based on the effective drug volume, combined with the drug concentration, ambient temperature and current nebulization rate, calculate the shortest nebulization time required to achieve the effective nursing dose; The formula for calculating is as follows: ; in, The minimum nebulization time required to achieve an effective nursing dose.

[0067] Step S34: The environmental comfort coefficient is calculated by coupling the ambient temperature and ambient humidity. Then, the optimal care time is calculated by combining the user care comfort weight, the longest nebulization time and the shortest nebulization time.

[0068] The formula for calculating the optimal nursing time is as follows: ; ; in, The environmental comfort coefficient ranges from 0.7 to 1.0. The user's comfort level is weighted, taking into account the nursing effect, user experience and environmental adaptability, with a preset value of 0.7~0.8.

[0069] Through the above three methods, this application constructs a three-parameter linkage back-inference system between drug solution parameters, nebulization rate and nursing time. The user can input any of the parameters as the initial condition, or the system can automatically generate suggested solutions based on the detected drug solution status. This allows the split-type nebulizing goggles to no longer be limited to a fixed nebulization mode, but to dynamically adjust the nursing strategy according to different drug solution conditions, different remaining drug solution amounts and different user needs.

[0070] In addition, the electronic control module 80 may not pre-set the drug solution parameter database and the nebulization parameter database, and therefore does not pre-store the remaining drug solution mapping table / curve, drug solution concentration mapping table / curve, and nebulization parameter back-calculation mapping table / curve (drug solution parameter back-calculation mapping table / curve, preset nursing time back-calculation mapping table / curve, drug solution parameter and current nebulization rate back-calculation mapping table / curve). Instead, the calculation of remaining medication volume and concentration based on medication pressure, light transmittance, and refraction angle is transferred to the electronic control module 80; the calculation of optimal atomization rate, atomization power, and optimal care time based on remaining medication volume and concentration (steps S11-S13) is transferred to the electronic control module 80; the calculation of optimal atomization rate and atomization power based on preset care time, remaining medication volume, and medication concentration (steps S21-S24) is transferred to the electronic control module 80; and the calculation of optimal care time based on current atomization rate, remaining medication volume, and medication concentration (steps S31-S34) is transferred to the electronic control module 80. This allows for more dynamic adjustments to the atomization system that better reflect the actual scenario.

[0071] It will be apparent to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above, and that the invention can be implemented in other specific forms without departing from its spirit or essential characteristics. Therefore, the embodiments should be considered in all respects as exemplary and non-limiting, and the scope of the invention is defined by the appended claims rather than the foregoing description. Thus, all variations falling within the meaning and scope of equivalents of the claims are intended to be included within the present invention. No reference numerals in the claims should be construed as limiting the scope of the claims.

[0072] Furthermore, it should be understood that although this specification describes embodiments, not every embodiment contains only one independent technical solution. This narrative style is merely for clarity. Those skilled in the art should consider the specification as a whole, and the technical solutions in each embodiment can also be appropriately combined to form other embodiments that can be understood by those skilled in the art.

Claims

1. A split-type atomizing eye mask, characterized in that, include: The eye mask and atomizer, The eye mask body is recessed inward to form an installation cavity. The middle of the installation cavity has an atomizing hole that runs through the inside and outside. The top of the installation cavity has an operating hole that runs through the inside and outside. The atomizer includes: an atomizer housing, a liquid storage chamber, a liquid storage chamber cover, a detachable liquid receiving cup, a wrap-around temperature and humidity regulating tube, an ultrasonic atomizing plate, a mist flow guide plate, and a mist outlet cover plate; the upper front part of the atomizer housing forms a liquid storage chamber assembly cavity, the lower front part of the atomizer housing forms a liquid receiving cup assembly cavity, and the middle rear part of the atomizer housing forms an atomizing cavity. The encapsulated heating and cooling regulating tube and the ultrasonic atomizing plate are installed in the atomizing chamber. The liquid storage tank is assembled in the liquid storage tank assembly chamber, and the liquid outlet of the liquid storage tank is connected to the left side of the ultrasonic atomizing plate. The mist inlet of the encapsulated heating and cooling regulating tube is connected to the right side of the ultrasonic atomizing plate. The lower section of the mist flow guide plate is rotatably or swingably assembled at the middle position of the mist outlet of the encapsulated heating and cooling regulating tube, and the upper section of the mist flow guide plate extends to the top of the encapsulated heating and cooling regulating tube. The rear part of the atomizer housing is assembled into the mounting cavity, the mist outlet of the enclosed heating and cooling regulating tube extends out of the atomizing hole, the top of the mist flow guide plate extends out of the operating hole, and the mist outlet cover is installed on the mist outlet of the enclosed heating and cooling regulating tube, and the mist outlet through holes on the left and right sides of the mist outlet cover are separated on both sides of the mist flow guide plate. The detachable liquid receiving cup is installed into the liquid receiving cup assembly cavity, and the liquid collection channel of the encapsulated hot and cold regulating tube extends forward and downward and connects to the detachable liquid receiving cup.

2. The split-type atomizing eye mask according to claim 1, characterized in that, The edge of the eye mask is connected to a soft, fitted part, and the two ends of the eye mask are connected to the back straps.

3. The split-type atomizing eye mask according to claim 1, characterized in that, The atomizer housing includes a front housing, a middle partition, and a rear housing; the liquid storage chamber includes a front chamber and a rear chamber. The atomizing chamber is located inside the rear shell. After the encapsulated heating and cooling regulating pipe and ultrasonic atomizing plate are installed inside the atomizing chamber, the rear side of the middle partition is connected to the front end of the rear shell, the rear end of the rear compartment is connected to the front side of the middle partition, the rear end of the front compartment is connected to the front end of the rear compartment, the upper circumferential surface of the front shell is connected to the lower circumferential surface of the front compartment, and the upper inner circumferential surface of the front shell is connected to the outer circumferential surface of the front compartment.

4. The split-type atomizing eye mask according to claim 3, characterized in that, The space between the upper part of the front shell and the middle partition is the liquid storage tank assembly cavity, the space between the lower part of the front shell and the rear shell is the liquid receiving cup assembly cavity, and the middle part of the front shell separates the liquid storage tank assembly cavity and the liquid receiving cup assembly cavity.

5. The split-type atomizing eye mask according to any one of claims 1 to 4, characterized in that, The encapsulated thermostatic control tube includes: a liquid collection channel, an outer tube body, a separator tube, a cooling semiconductor, and a heating element; The upper end of the liquid collection channel is connected to the bottom of the outer tube. The separator is located inside the outer tube and there is a gap between the separator and the outer tube. The cooling semiconductor is arranged around the gap between the separator and the outer tube, and the heating element is attached to the inner side of the separator.

6. The split-type atomizing eye mask according to any one of claims 1 to 4, characterized in that, The lower section of the mist distribution guide plate is the guide plate itself, while the upper section consists of a connecting rod and an operating panel. The lower end of the connecting rod is connected to the upper end of the guide plate, and the upper end of the connecting rod is connected to the lower end of the operating disc. The circumference of the operating disc has an operating protrusion that extends out of the operating hole.

7. An adaptive atomization care system for a split-type atomizing eye mask, characterized in that, include: Pressure sensor, optical sensor, setting input module and electronic control module; The pressure sensor is located on the bottom or side wall of the liquid storage chamber, the optical sensor is located on the side wall of the liquid storage chamber, the setting input module is installed on the atomizer housing, and the electronic control module is located inside the atomizer housing, and the electronic control module is located outside the liquid storage chamber assembly cavity, the liquid receiving cup assembly cavity and the atomizing cavity. The pressure sensor detects the pressure of the liquid medicine in the storage tank and transmits it to the electronic control module. The optical sensor detects the light transmittance and refraction angle of the liquid medicine in the storage tank and transmits them to the electronic control module. The setting input module detects the preset nursing duration or the current mist rate input by the user and transmits it to the electronic control module. The electronic control module runs a drug liquid parameter database. The electronic control module queries the remaining drug liquid mapping table / curve in the drug liquid parameter database by the drug liquid pressure to obtain the remaining drug liquid in the storage tank. The electronic control module queries the drug liquid concentration mapping table / curve in the drug liquid parameter database by the drug liquid transmittance and drug liquid refraction angle to obtain the drug liquid concentration in the storage tank. The electronic control module has a pre-set nebulization parameter database. The electronic control module queries the nebulization parameter back-mapping mapping table / curve in the nebulization parameter database using the remaining amount and concentration of the medication to obtain the optimal nebulization rate, nebulization power, and optimal care time. Alternatively, it queries the nebulization parameter back-mapping mapping table / curve in the nebulization parameter database using the preset care time, remaining amount and concentration of the medication to obtain the optimal nebulization rate and nebulization power. Or, it queries the nebulization parameter back-mapping mapping table / curve in the nebulization parameter database using the current nebulization rate, remaining amount and concentration of the medication to obtain the optimal care time. Based on the optimal nebulization rate, nebulization power, and optimal care time, the electronic control module issues nebulization commands.

8. The adaptive atomizing care system for the split-type atomizing eye mask according to claim 7, characterized in that, A back-mapping mapping table / curve for nebulization parameters is constructed by establishing the mapping relationship between medication parameters, optimal nebulization rate, nebulization power, and optimal care time. The steps for obtaining the mapping relationship between medication parameters, optimal nebulization rate, nebulization power, and optimal care time are as follows: Step S11: Combine the drug concentration with the introduced drug time-effect decay coefficient to calculate the effective drug volume required to complete the nursing care. Step S12: Calculate the optimal atomization rate by combining the drug concentration with the ambient temperature and humidity, and calculate the atomization power by combining the optimal atomization rate with the drug concentration and ambient temperature. Step S13: Calculate the optimal nursing time based on the optimal atomization rate, effective drug volume, remaining drug volume, and rated capacity of the storage tank.

9. The adaptive atomizing care system for a split-type atomizing eye mask according to claim 7, characterized in that, A back-mapping mapping table / curve for nebulization parameters is constructed by establishing a mapping relationship between preset nursing time, medication parameters, optimal nebulization rate, and nebulization power. The steps for obtaining the mapping relationship between preset nursing time, medication parameters, optimal nebulization rate, and nebulization power are as follows: Step S21: Combine the remaining amount of medication with the introduced medication time-effect decay coefficient to determine the maximum volume of medication that can be atomized within the preset nursing time. Step S22: Based on the maximum volume of atomizable liquid and the preset nursing time, calculate the basic atomization rate initially, and then make the first correction to the basic atomization rate by combining the ambient temperature and humidity to obtain the first correction atomization rate. Step S23: Calculate the viscosity of the drug solution by the transmittance of the drug solution, and then make a second correction to the atomization rate of the first repair by combining the drug solution concentration to obtain the atomization rate of the second repair. Step S24: Introduce user self-learning correction to make final correction to the secondary atomization rate, obtain the optimal atomization rate, and calculate the atomization power by combining the optimal atomization rate with the drug concentration and ambient temperature.

10. The adaptive atomizing care system for a split-type atomizing eye mask according to claim 7, characterized in that, A back-mapping table / curve for nebulization parameters is constructed by mapping the current nebulization rate and medication parameters to the optimal care time. The steps for obtaining the mapping relationship between the current nebulization rate and medication parameters to the optimal care time are as follows: Step S31: Under the current atomization rate, after considering the decay of atomization efficiency, calculate the longest atomization time that the remaining amount of medicine can support; Step S32: Combine the drug concentration with the introduced drug time-effect decay coefficient to calculate the effective drug volume required to complete the nursing care; Step S33: Based on the effective drug volume, combined with the drug concentration, ambient temperature and current nebulization rate, calculate the shortest nebulization time required to achieve the effective nursing dose; Step S34: The environmental comfort coefficient is calculated by coupling the ambient temperature and ambient humidity. Then, the optimal care time is calculated by combining the user care comfort weight, the longest nebulization time and the shortest nebulization time.

Images